MiMedx Group, Inc. (NASDAQ:MDXG) has a beta value of 1.57 and has seen 352,741 shares traded in the last trading session. The company, currently valued at $754Million, closed the last trade at $6.61 per share which meant it lost -$0.18 on the day or -2.65% during that session. The MDXG stock price is -20.27% off its 52-week high price of $7.95 and 55.37% above the 52-week low of $2.95. If we look at the company’s 10-day average daily trading volume, we find that it stood at 654.59 Million shares traded. The 3-month trading volume is 233.42 Million shares.
The consensus among analysts is that MiMedx Group, Inc. (MDXG) is a Hold stock at the moment, with a recommendation rating of 3. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 1 have rated it as a Hold, with no one of them advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.
MiMedx Group, Inc. (NASDAQ:MDXG) trade information
Despite being -2.65% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Nov 18 when the MDXG stock price touched $7.20-8 or saw a rise of 8.19%. Year-to-date, MiMedx Group, Inc. shares have moved -12.8%, while the 5-day performance has seen it change 5.42%. Over the past 30 days, the shares of MiMedx Group, Inc. (NASDAQ:MDXG) have changed 2.16%. Short interest in the company has seen 61.28 Million shares shorted with days to cover at 0.26.
Wall Street analysts have a consensus price target for the stock at $9, which means that the shares’ value could jump 36.16% from current levels. The projected low price target is $9 while the price target rests at a high of $9. In that case, then, we find that the current price level is +36.16% off the targeted high while a plunge would see the stock lose 36.16% from current levels.
MiMedx Group, Inc. (MDXG) estimates and forecasts
1 analysts offering their estimates for the company have set an average revenue estimate of $84.5 Million for the current quarter. 1 have an estimated revenue figure of $90.4 Million for the next quarter concluding in June 01, 2018. Year-ago sales stood $72.61 Million and $76.41 Million respectively for this quarter and the next, and analysts expect sales will grow by 16.4% for the current quarter and 18.3% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -44.8% over the past 5 years. Earnings growth for 2020 is a modest +15.7% while over the next 5 years, the company’s earnings are expected to increase by 15%.
MiMedx Group, Inc. (NASDAQ:MDXG)’s Major holders
Insiders own 6.29% of the company shares, while shares held by institutions stand at 12.28% with a share float percentage of 13.11%. Investors are also buoyed by the number of investors in a company, with MiMedx Group, Inc. having a total of 25 institutions that hold shares in the company. The top two institutional holders are RTW Investments LP with over 2.7 Million shares worth more than $17.16 Million. As of September 29, 2020, RTW Investments LP held 2.45% of shares outstanding.
The other major institutional holder is Acuitas Investments LLC, with the holding of over 431.54 Thousand shares as of September 29, 2020. The firm’s total holdings are worth over $2.74 Million and represent 0.39% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Thompson Large Cap Fund and Forum Funds II-Acuitas U.S. Micro Cap Fund. As of September 29, 2020, the former fund manager holds about 0.05% shares in the company for having 57600 shares of worth $366.05 Thousand while later fund manager owns 48.1 Thousand shares of worth $305.65 Thousand as of September 29, 2020, which makes it owner of about 0.04% of company’s outstanding stock.